Sarah Cannon Research Institute
Cassie L. has extensive experience in clinical data management and analysis, currently serving as a Sr. Clinical Data Manager at Sarah Cannon Research Institute since November 2013, leading data science activities for Phase I-II oncology clinical research trials. Cassie L. has also held positions including Clinical Data Manager and Principle Data Analyst, contributing to process improvements and coordinating departmental training. Prior to Sarah Cannon, Cassie L. was a CORES Database Liaison at Vanderbilt University Medical Center, providing administrative support and training for a research core facility database, and worked as an Administrative Assistant at Eli Lilly and Company, supporting medical division projects. Cassie L. holds a Bachelor of Science degree from Liberty University, obtained in 2007.
This person is not in the org chart
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.